Navigation Links
Allsup Outlines 10 Essential Questions People Need to Ask when Evaluating Medicare Plans
Date:12/17/2008

Medicare Advantage plans, which are provided by private companies approved by Medicare. Because traditional Medicare has fairly high deductibles, co-payments and co-insurance, many people also purchase Medigap supplemental coverage. You do not need Medigap coverage with Medicare Advantage plans.

2.   Does the plan cover pre-existing conditions?

Generally, Medigap does not cover pre-existing conditions. As a result, for many people with disabilities, traditional Medicare with Medigap supplemental coverage is not the best option. Medicare Advantage plans, conversely, are required to cover pre-existing conditions.

3.   Do my doctors accept the plan?

Physicians and hospitals are required to accept traditional Medicare, but they choose whether or not to participate in Medicare Advantage plans. Within Medicare Advantage plans, people selecting Preferred Provider Organization (PPO) plans will have more flexibility in selecting doctors or hospitals than those choosing Health Maintenance Organization (HMO) plans. However, HMOs may be more cost effective if a beneficiary's chosen physician is a part of an available HMO plan.

4.   Does the plan cover my prescription drugs?

Individuals with traditional Medicare do not have prescription drug coverage unless they also enroll in and pay an additional fee for a Medicare prescription drug plan (PDP). Most Medicare Advantage plans incorporate prescription drug coverage. Beyond the prescription drug premium cost, individuals need to look carefully at plan co-pays, deductibles and co-
'/>"/>

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Page: 1 2 3 4 5 6

Related medicine news :

1. Look Before You Leap: Allsup Cautions Medicare Recipients about the Prescription Drug Donut Hole
2. Allsup Finds Healthcare Costs Consuming Larger Part of Fixed Incomes
3. New Medicare Advantage Marketing Rules Help People Make Informed Choices, Allsup Says
4. Traditional Medicare vs. Medicare Advantage Plans: Allsup Finds Knowing the Differences Means Savings for People with Disabilities
5. Social Security 2009 COLA Helps, But People with Disabilities Will Still Struggle, Says Allsup
6. Allsup Introduces Health Discount Program to Millions of People with Disabilities
7. Allsup's New Medicare Advisor Program Helps People with Disabilities Make Sound Healthcare Coverage Decisions
8. Allsup Outlines Five Critical Issues for Caregivers Preparing to Take on Financial and Healthcare Responsibilities
9. Allsup Salutes 18th Anniversary of Americans with Disabilities Act
10. National CTE Research Center Outlines Projects
11. New statement outlines essentials of heart failure clinics
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Allsup Outlines 10 Essential Questions People Need to Ask when Evaluating Medicare Plans
Allsup Outlines 10 Essential Questions People Need to Ask when Evaluating Medicare Plans
Breaking Medicine Technology:Maxygen, Inc. Announces Extension of Dutch Auction Tender Offer 2Boston Scientific Announces Pricing of $2 Billion of Senior Notes 2Boston Scientific Announces Pricing of $2 Billion of Senior Notes 3Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 2Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 3Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 4Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 5Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 6Chicken Pox Vaccine May Also Reduce Risk of Shingles Among Children 62585 1Chicken Pox Vaccine May Also Reduce Risk of Shingles Among Children 62585 2Chicken Pox Vaccine May Also Reduce Risk of Shingles Among Children 62585 3Senate Approval of Mikulski Amendment Further Opens Health Care Bill to Massive Federal Funding of Abortion 62581 1Senate Approval of Mikulski Amendment Further Opens Health Care Bill to Massive Federal Funding of Abortion 62581 2Ginger Prices Could Skyrocket on H1N1 Fears 62576 1Ginger Prices Could Skyrocket on H1N1 Fears 62576 2